Profilo
Lin Ni is currently the Managing Director at 6 Dimensions Capital since 2017 and an Independent Non-Executive Director at TenNor Therapeutics Suzhou Ltd. starting in 2025.
Former positions include Managing Director at Frontline Bioventures, Director at Shanghai Ark Biopharmaceutical Co., Ltd. in 2021, and Non-Executive Director at Edding Genor Group Holdings Ltd. from 2021 to 2022.
Education includes a doctorate degree from Osaka University conferred in 2009.
Posizioni attive di Lin Ni
| Società | Posizione | Inizio |
|---|---|---|
| TENNOR THERAPEUTICS (SUZHOU) LIMITED | Direttore/Membro del Consiglio | 08/07/2025 |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Investitore di Private Equity | 18/05/2017 |
Precedenti posizioni note di Lin Ni
| Società | Posizione | Fine |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Direttore/Membro del Consiglio | 29/07/2022 |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Direttore/Membro del Consiglio | 18/05/2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in biopharmaceutical services | Direttore/Membro del Consiglio | - |
Formazione di Lin Ni
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Osaka University
Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in biopharmaceutical services | Health Technology |
TenNor Therapeutics Suzhou Ltd.
TenNor Therapeutics Suzhou Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which engages in discovery, development and commercialization of therapies for bacterial infections and metabolism | Health Technology |
Genor Biopharma Holdings Ltd.
Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
















